News & events

10,000 people could benefit from new migraine drug

Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.

By NIHR Maudsley BRC at 12 Mar 2020

Study finds that Community Treatment Orders do not reduce hospital readmission rates or stays

In the first large, observational study with a control group in England and Wales, research funded by the NIHR Maudsley Biomedical Research Centre has found that Community Treatment Orders (CTOs) are associated with an increased risk of readmission as well as increased time spent in psychiatric hospitals, contrary to results from previous uncontrolled studies. Researchers suggest that these findings should be considered in future reforms to the UK Mental Health Act.

By NIHR Maudsley BRC at 5 Mar 2020

CRIS Blog: Artificial Intelligence and Data in Suicide Prevention

This blog was written by Dr Rina Dutta, Senior Clinical Lecturer and Consultant Psychiatrist at IoPPN. She tweets @rina_dutta

By NIHR Maudsley BRC at 2 Mar 2020

Largest ever study of eating disorders launches in England

A National Institute for Health Research (NIHR) funded study launched today (Wednesday 26 February) is aiming to recruit at least 10,000 people in England who have experienced an eating disorder at some point in their life to a pioneering new study that aims to unlock the secrets of eating disorders.

By NIHR Maudsley BRC at 26 Feb 2020

CRIS Blog: Appropriate use of healthcare records for research

CRIS has been used by researchers for over 10 years now and has supported somewhere between 150 and 200 research papers, as well as helping to transform the way in which SLaM learns from its clinical practice

By NIHR Maudsley BRC at 12 Feb 2020